Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine and clonidine for pain control after laparoscopic cholecystectomy
IRCT20180424039401N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine and clonidine in postoperative pain and postoperative nausea and vomiting (PONV) (3 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: abdominal pain, shoulder pain and 2 more. Started Dec 2017; status: completed.
02
Drugs
bupivacaineclonidine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20180424039401N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180424039401N1.